Location History:
- Berks, GB (1993)
- Slough, GB (1991 - 1994)
Company Filing History:
Years Active: 1991-1994
Title: Marie G McKenniff: A Trailblazer in Antithrombotic Innovations
Introduction
Marie G McKenniff, based in Slough, GB, is a distinguished inventor recognized for her significant contributions in the field of medicinal chemistry, particularly in the area of antithrombotic agents. With a portfolio of five patents, McKenniff has demonstrated her innovative spirit and commitment to advancing healthcare solutions.
Latest Patents
Among her most notable recent patents, McKenniff developed two key formulations aimed at treating various medical conditions. The first patent covers “Antithrombotic substituted cycloalkano (B) dihydroindole sulphonamides,” which focuses on employing these compounds for the treatment of thromboses, thromboembolisms, ischaemias, asthma, and allergies. The structural formula includes specific radicals represented as R¹, R², R³, and R⁴.
Her second significant patent involves “Antithrombotic iso- and heterocyclic phenylsulphonamides.” This invention describes the preparation methods for iso- and heterocyclic phenylsulphonamides through reactions with phenylsulphonic acid derivatives. These compounds exhibit thrombocyte aggregation-inhibiting properties and antagonistic action against thromboxane A₂, making them valuable in medicament formulation.
Career Highlights
Marie G McKenniff is affiliated with Bayer Aktiengesellschaft, a leading global enterprise in pharmaceuticals and life sciences. Her work at Bayer emphasizes her role in pioneering efforts to enhance antithrombotic therapies that can significantly improve patient outcomes in critical health conditions.
Collaborations
Throughout her career, McKenniff has collaborated with esteemed professionals in her field, including Elisabeth Perzborn and Volker-Bernd Fiedler. These partnerships reflect a spirit of teamwork and shared expertise driving innovation in pharmaceutical development and research.
Conclusion
Marie G McKenniff stands out as a prominent figure in the landscape of antithrombotic drug development. Her inventive contributions have the potential to revolutionize the treatment of various medical ailments, highlighting her as an influential inventor committed to advancing healthcare. With her ongoing work, McKenniff continues to inspire future generations of scientists and inventors.